ENVALITH
ホクト株式会社 logo

HOKUTO CORPORATION

1379・Prime Market・Fishery, Agriculture & Forestry

Official website
ホクト株式会社 logo
HOKUTO CORPORATION1379

Business

Hokuto Corporation is a food manufacturer whose core operations are the research and development, production, and sales of facility-cultivated mushrooms, centered on Bunashimeji, Eringi, and Maitake. It operates 33 production centers across 20 locations nationwide, with the "Domestic Mushroom Business" — serving mainly mass retailers, co-ops, and wholesale markets — as its core segment. The company is organized into four segments: the "Domestic Mushroom Business"; the "Overseas Mushroom Business," comprising three overseas sites in the US, Taiwan, and Malaysia; the "Processed Products Business," handling processed mushroom products, retort pouch foods, and health foods; and the "Chemical Products Business," dealing in packaging materials, agricultural materials, and industrial materials. Consolidated net sales for FY2026 (ending March 2026) were ¥85,915 million, with the Domestic Mushroom Business accounting for approximately 65% of sales.

Business Model

The company employs a vertically integrated model spanning from production to sales, with the core of its competitive advantage being a freshness-focused supply system that delivers mushrooms harvested at 33 production centers nationwide to mass retailer storefronts the next day. While the core domestic mushroom business generates segment profit of ¥7,242 million (profit margin of approximately 12.9%), the processed foods and chemical products businesses supplement earnings. R&D investment (¥734 million) in new variety development and high-value-added product deployment contributes to maintaining and enhancing prices.

Company Strengths

Domestic mushroom production is organized across 33 production centers in 20 locations nationwide, grouped into 9 regions, forming a fresh direct-delivery system that reaches retail store shelves the day after harvest. This nationwide production and logistics infrastructure is the result of years of accumulated capital investment, forming a barrier to entry that competitors cannot easily replicate in the short term. Domestic mushroom business net sales reached ¥56,077 million in FY2026 (ending March 2026).

Starting from the Mushroom Research Institute established in 1983, the company has continuously developed new varieties such as Bunashimeji, Eringi, and Maitake. In FY2026 (ending March 2026), it launched a new Eringi variety resulting from its first varietal improvement in 26 years, and obtained multiple variety registrations in South Korea and Europe. R&D expenses amounted to ¥734 million, supporting the development of premium products such as its proprietary variety "Shimofuri Hiratake" (marbled oyster mushroom).

At the end of FY2026 (ending March 2026), the equity ratio stood at 57.1% (up 4.3 percentage points year on year), and operating cash flow was ¥10,824 million. The interest-bearing debt-to-cash-flow ratio remained low at 1.9 years, reflecting a financial base capable of funding capital expenditures (¥4,859 million) and dividends (¥1,590 million) from internal resources.

ENVALITH's Perspective

Net income of ¥7,006 million for FY2026 (ending March 2026) includes ¥1,915 million (extraordinary income) in confirmed insurance proceeds related to the fire at the Ueda No.1 Mushroom Center. The company's FY2027 (ending March 2027) forecast for net income is ¥5,250 million (down 25.1% year on year), mainly due to the disappearance of this extraordinary income. Core business operating profit is forecast to increase to ¥7,260 million (up 3.3% year on year), while ordinary profit is expected to decline to ¥7,650 million (down 6.6% year on year), also affected by a reduction in financial income. Investors need to assess the company's underlying earnings power excluding one-time gains.

In FY2026 (ending March 2026), sales in the overseas mushroom business were ¥8,236 million (up 6.8% year on year), an increase in revenue. However, all three overseas locations fell short of initial plans: the U.S. due to unsuccessful bidding with major customers and weakening demand, Taiwan due to a market slump from oversupply of vegetables, and Malaysia due to overall sluggish sales. The revenue increase was mainly driven by the boost from yen conversion amid the weaker yen, so the underlying performance in local currency terms should be viewed with caution. Attention should be paid to the structural sensitivity of results to exchange rate trends as an external factor.

In FY2026 (ending March 2026), mushroom prices remained firm due to the "Kinoko de Kinkatsu" (mushrooms for gut health) campaign and SNS promotions for Shimofuri Hiratake (marbled oyster mushroom), among other initiatives, leading to segment profit of ¥7,242 million (up 3.5% year on year) in the domestic mushroom business. The processed food business also improved, supported by strong demand from the food service, prepared foods, and takeout channels as well as expanded OEM business at Arden, resulting in segment profit of ¥511 million (up 36.5% year on year). On the other hand, upward pressure from rising energy costs, logistics costs, and labor costs continues, and the effectiveness of cost reductions through DX/labor-saving and procurement optimization is a prerequisite for maintaining an operating profit margin in the 8% range.

Growth Strategy

Promoting a new medium-term management plan built on four pillars: enhancing value-added products domestically, expanding overseas operations, strengthening the processed products business, and advancing DX.

Promoting the "Kinoko de Kinkatsu" (mushroom fermented-food lifestyle) campaign built around three pillars—health, beauty, and sports—alongside SNS and in-store promotions for premium mushrooms such as Shimofuri Hiratake (marbled oyster mushroom). In November 2025, launched a new King Trumpet mushroom variety developed through breed improvement for the first time in 26 years, strengthening product competitiveness. In FY2026 (ending March 2026), the domestic mushroom business achieved net sales of ¥56,077 million and segment profit of ¥7,242 million.

Working to reduce costs through the promotion of energy management, efficiency improvements via DX/labor-saving measures, and optimization of procured materials. Amid continued increases in logistics costs, personnel expenses, and energy costs, the company has maintained an operating margin of 8.2% (FY2026, ending March 2026), confirming a certain level of effectiveness.

Promoting stronger local marketing, improved factory utilization rates, and new customer development across three bases in the US, Taiwan, and Malaysia. In FY2026 (ending March 2026), net sales reached ¥8,236 million (up 6.8% year on year) thanks to the effect of the weaker yen, but all three bases fell short of plan in local currency terms. The company will continue to focus on this area as a key growth field.

Promoting expansion of sales of commercial-use products for restaurants, delicatessens, and prepared meals, growth of the subscription customer base for dried mushrooms and health foods in mail-order sales, and expansion of the OEM business at subsidiary Arden. In FY2026 (ending March 2026), segment profit improved significantly to ¥511 million (up 36.5% year on year), and this business is positioned as a key growth field.

Promoting the capture of demand for environmentally friendly packaging materials such as recycled products and biomass products, strengthening SDGs-related initiatives, and expanding the in-house products division through the start of production of newly ordered products. In FY2026 (ending March 2026), achieved a significant increase in profit with net sales of ¥13,598 million (up 12.1% year on year) and segment profit of ¥470 million (up 39.2% year on year).

Last updated: July 19, 2026